A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk

Journal of Lipid Research

Volumn 49, Issue 3, 2008, Pages 588-596

  Crawford, Dana C ^a   Nord, Alex S ^b   Badzioch, Michael D ^b   Ranchalis, Jane ^b   McKinstry, Laura A ^b   Ahearn, Magdalena ^c   Bertucci, Caterina ^c   Shephard, Cynthia ^c   Wong, Michelle ^c   Rieder, Mark J ^c   Schellenberg, Gerard D ^c   Nickerson, Deborah A ^c   Heagerty, Patrick J ^c   Wijsman, Ellen M ^b,c   Jarvik, Gail P ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apolipoprotein E; Body mass index; Triglycerides; Very low density lipoprotein receptor

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; DNA FLANKING REGION; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; RISK FACTOR;

5' FLANKING REGION; APOLIPOPROTEINS B; APOLIPOPROTEINS E; BODY MASS INDEX; CAROTID ARTERY DISEASES; DNA MUTATIONAL ANALYSIS; EPIDEMIOLOGY, MOLECULAR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LDL; RISK FACTORS;

EID: 42949136636     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700409-JLR200     Document Type: Article

References (74)

1. Sakai, J., A. Hoshino, S. Takahashi, Y. Miura, H. Ishii, H. Suzuki, Y. Kawarabayasi, and T. Yamamoto. 1994. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J. Biol. Chem. 269: 2173-2182.
2. Webb, J. C., D. D. Patel, M. D. Jones, B. L. Knight, and A. K. Soutar. 1994. Characterization and tissue-specific expression of the human Fvery low density lipoprotein (VLDL) receptor' mRNA. Hum. Mol. Genet. 3: 531-537.
3. Takahashi, S., Y. Kawarabayasi, T. Nakai, J. Sakai, and T. Yamamoto. 1992. Rabbit very low density lipoprotein receptor: a low density lipoprotein density receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA. 89: 9252-9256.
4. Patel, D. D., R. A. Forder, A. K. Soutar, and B. L. Knight. 1997. Synthesis and properties of the very-low-density-lipoprotein receptor and a comparison with the low-density-lipoprotein receptor. Biochem. J. 324: 371-377.
5. Takahashi, S., J. Suzuki, M. Kohno, K. Oida, T. Tamai, S. Miyabo, T. Yamamoto, and T. Nakai. 1995. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J. Biol. Chem. 270: 15747-15754.
6. Tissir, F., and A. M. Goffinet. 2003. Reelin and brain development. Nat. Rev. Neurosci. 4: 496-505.
7. Frykman, P. K., M. S. Brown, T. Yamamoto, J. L. Goldstein, and J. Herz. 1995. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92: 8453-8457.
8. Yagyu, H., E. P. Lutz, Y. Kako, S. Marks, Y. Hu, S. Y. Choi, A. Bensadoun, and I. J. Goldberg. 2002. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J. Biol. Chem. 277: 10037-10043.
9. Tacken, P. J., B. Teusink, M. C. Jong, D. Harats, L. M. Havekes, K. W. van Dijk, and M. H. Hofker. 2000. LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice. J. Lipid Res. 41: 2055-2062.
10. Goudriaan, J. R., P. J. Tacken, V. E. H. Dahlmans, M. J. J. Gijbels, K. W. van Dijk, L. M. Havekes, and M. C. Jong. 2001. Protection from obesity in mice lacking the VLDL receptor. Arterioscler. Thromb. Vasc. Biol. 21: 1488-1493.
11. Boycott, K. M., S. Flavelle, A. Bureau, H. C. Glass, T. M. Fujiwara, E. Wirrell, K. Davey, A. E. Chudley, J. N. Scott, D. R. McLeod, et al. 2005. Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am. J. Hum. Genet. 77: 477-483.
12. Badzioch, M. D., R. P. Igo, Jr., F. Gagnon, J. D. Brunzell, R. M. Krauss, A. G. Motulsky, E. M. Wijsman, and G. P. Jarvik. 2004. Low-density lipoprotein particle size loci in familial combined hyperlipidemia: evidence for multiple loci from a genome scan. Arterioscler. Thromb. Vasc. Biol. 24: 1942-1950.
13. Mineva, P. P., I. C. Manchev, and D. I. Hadjiev. 2002. Prevalence and outcome of asymptomatic carotid stenosis: a population-based ultrasonographic study. Eur. J. Neurol. 9: 383-388.
14. Goessens, B. M. B., F. L. J. Visseren, A. Algra, J. D. Banga, and Y. van der Graaf. 2006. Screening for asymptomatic cardiovascular disease with noninvasive imaging in patients at high-risk and low-risk according to the European Guidelines on Cardiovascular Disease Prevention: the SMART study. J. Vasc. Surg. 43: 525-532.
15. Goessens, B. M. B., F. L. J. Visseren, L. J. Kappelle, A. Algra, and Y. van der Graaf for the SMART Study Group. 2007. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease: the SMART study. Stroke. 38: 1470-1475.
16. Lorenz, M. W., H. S. Markus, M. L. Bots, M. Rosvall, and M. Sitzer. 2007. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 115: 459-467.
17. Sharrett, A. R., P. D. Sorlie, L. E. Chambless, A. R. Folsom, R. G. Hutchinson, G. Heiss, and M. Szklo. 1999. Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence: the Atherosclerosis Risk in Communities Study. Am. J. Epidemiol. 149: 843-852.
18. Wilson, P. W. F., J. M. Hoeg, R. B. D'Agostino, H. Silbershatz, A. M. Belanger, H. Poehlmann, D. O'Leary, and P. A. Wolf. 1997. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N. Engl. J. Med. 337: 516-522.
19. Osterud, B., and E. Bjorklid. 2003. Role of monocytes in atherogenesis. Physiol. Rev. 83: 1069-1112.
20. Jarvik, G. P., L. S. Rozek, V. H. Brophy, T. S. Hatsukami, R. J. Richter, G. D. Schellenberg, and C. E. Furlong. 2000. Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1192 or PON155 genotype. Arterioscler. Thromb. Vasc. Biol. 20: 2441-2447.
21. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
22. Bachorik, P., and J. J. Albers. 1986. Precipitation methods for quantification of lipoproteins. Methods Enzymol. 129: 78-100.
23. Warnick, G. 1986. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol. 129: 101-123.
24. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-501.
25. Marcovina, S. M., J. J. Albers, L. O. Henderson, and W. H. Hannon. 1993. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material. Clin. Chem. 39: 773-781.
26. Zambon, A., M. A. Austin, B. G. Brown, J. E. Hokanson, and J. D. Brunzell. 1993. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler. Thromb. 13: 147-153.
27. Auwerx, J. H., C. A. Marzetta, J. E. Hokanson, and J. D. Brunzell. 1989. Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis. 9: 319-325.
28. The International HapMap Consortium. 2005. A haplotype map of the human genome. Nature. 437: 1299-1320.
29. Stephens, M., J. S. Sloan, P. D. Robertson, P. Scheet, and D. A. Nickerson. 2006. Automating sequence-based detection and genotyping of SNPs from diploid samples. Nat. Genet. 38: 375-381.
30. Ng, P. C., and S. Henikoff. 2003. SIFT: predicting aminoacid changes that affect protein function. Nucleic Acids Res. 31: 3812-3814.
31. Ramensky, V., P. Bork, and S. Sunyaev. 2002. Human nonsynonymous SNPs: server and survey. Nucleic Acids Res. 30: 3894-3900.
32. De La Vega, F. M., K. D. Lazaruk, M. D. Rhodes, and M. H. Wenz. 2005. Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP genotyping assays and the SNPlex genotyping system. Mutat. Res. 573: 111-135.
33. Carlson, C. S., M. A. Eberle, M. J. Rieder, Q. Yi, and L. Kruglyak. 2004. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74: 106-120.
34. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. Ser. B. Methodological. 57: 289-300.
35. Haines, J. L., N. Schnetz-Boutaud, S. Schmidt, W. K. Scott, A. Agarwal, E. A. Postel, L. Olson, S. J. Kenealy, M. Hauser, J. R. Gilbert, et al. 2006. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest. Ophthalmol. Vis. Sci. 47: 329-335.
36. Eichner, J. E., S. T. Dunn, G. Perveen, D. M. Thompson, K. E. Stewart, and B. C. Stroehla. 2002. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 155: 487-495.
37. Hiltunen, T. P., J. S. Luoma, T. Nikkari, and S. Yla-Herttuala. 1998. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation. 97: 1079-1086.
38. Qu, S., F. Wu, J. Tian, Y. Li, Y. Wang, Y. Wang, and Y. Zong. 2004. Role of VLDLR receptor in the process of foam cell formation. J. Huazhong Univ. Sci. Technolog. Med. Sci. 24: 1-4.
39. Kosaka, S., S. Takahashi, K. Masamura, H. Kanehara, J. Sakai, G. Tohda, E. Okada, K. Oida, T. Iwasaki, H. Hattori, et al. 2001. Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages. Circulation. 103: 1142-1147.
40. Hoe, H. S., and G. W. Rebeck. 2005. Regulation of apoE receptor proteolysis by ligand binding. Brain Res. Mol. Brain Res. 137: 31-39.
41. Hatters, D. M., C. A. Peters-Libeu, and K. H. Weisgraber. 2006. Apolipoprotein E structure: insights into function. Trends Biochem. Sci. 31: 445-454.
42. Djousse, L., R. H. Myers, M. A. Province, S. C. Hunt, J. H. Eckfeldt, G. Evans, J. M. Peacock, and R. C. Ellison. 2002. Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke. 33: 1357-1361.
43. Tabara, Y., K. Kohara, J. Nakura, and T. Miki. 2001. Risk factor-gene interaction in carotid atherosclerosis: effect of gene polymorphisms of renin-angiotensin system. J. Hum. Genet. 46: 278-284.
44. Debette, S., J. C. Lambert, J. Gariepy, N. Fievet, C. Tzourio, J. F. Dartigues, K. Ritchie, A. M. Dupuy, A. Alperovitch, P. Ducimetiere, et al. 2006. New insight into the association of apolipoprotein E genetic variants with carotid plaques and intima-media thickness. Stroke. 37: 2917-2923.
45. Guz, G., O. F. Nurhan, S. Sezer, I. Isiklar, Z. Arat, M. Turan, and M. Haberal. 2000. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients. Am. J. Kidney Dis. 36: 826-836.
46. Olmer, M., J. E. Renucci, R. Planells, D. Bouchouareb, and R. Purgus. 1997. Preliminary evidence for a role of apolipoprotein E alleles in identifying haemodialysis patients at high vascular risk. Nephrol. Dial. Transplant. 12: 691-693.
47. Elosua, R., J. M. Ordovas, L. A. Cupples, C. S. Fox, J. F. Polak, P. A. Wolf, R. A. D'Agostino, Sr., and C. J. O'Donnell. 2004. Association of APOE genotype with carotid atherosclerosis in men and women: the Framingham Heart Study. J. Lipid Res. 45: 1868-1875.
48. Haraki, T., T. Takegoshi, C. Kitoh, T. Wakasugi, T. Saga, J. I. Hirai, T. Aoyama, A. Inazu, and H. Mabuchi. 2002. Carotid artery intima-media thickness and brachial artery flow-mediated vasodilation in asymptomatic Japanese male subjects amongst apolipoprotein E phenotypes. J. Intern. Med. 252: 114-120.
49. Karvonen, J., H. Kauma, K. Kervinen, O. Ukkola, M. Rantala, M. Paivansalo, M. J. Savolainen, and Y. A. Kesaniemi. 2002. Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men. J. Hypertens. 20: 2371-2378.
50. de Andrade, M., I. Thandi, S. Brown, A. Gotto, Jr., W. Patsch, and E. Boerwinkle. 1995. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am. J. Hum. Genet. 56: 1379-1390.
51. Terry, J. G., G. Howard, M. Mercuri, M. G. Bond, and J. R. Crouse, III. 1996. Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening. Stroke. 27: 1755-1759.
52. Cattin, L., M. Fisicaro, M. Tonizzo, M. Valenti, G. M. Danek, M. Fonda, P. G. Da Col, S. Casagrande, E. Pincetti, M. Bovenzi, et al. 1997. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults. Arterioscler. Thromb. Vasc. Biol. 17: 91-94.
53. Vauhkonen, I., L. Niskanen, M. Ryynanen, R. Voutilainen, J. Partanen, J. Tovry, M. Mercuri, R. Rauramaa, and M. Uusitupa. 1997. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects. Diabet. Med. 14: 748-756.
54. Kogawa, K., Y. Nishizawa, M. Hosoi, T. Kawagishi, K. Maekawa, T. Shoji, Y. Okuno, and H. Morii. 1997. Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness. Diabetes. 46: 682-687.
55. Zannad, F., S. Visvikis, R. Guequen, C. Sass, O. Chapet, B. Herbeth, and G. Siest. 1998. Genetics strongly determines the wall thickness of the left and right carotid arteries. Hum. Genet. 103: 183-188.
56. Ilveskoski, E., A. Loimaala, M. F. Mercuri, T. Lehtimaki, M. Pasanen, A. Nenonen, P. Oja, M. G. Bond, T. Koivula, P. J. Karhunen, et al. 2000. Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men. Atherosclerosis. 153: 147-153.
57. Slooter, A. J. C., M. L. Bots, L. M. Havekes, A. I. del Sol, M. Cruts, D. E. Grobbee, A. Hofman, C. Van Broeckhoven, J. C. M. Witteman, and C. M. van Duijn. 2001. Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam study. Stroke. 32: 1947-1952.
58. Beilby, J. P., C. C. J. Hunt, L. J. Palmer, C. M. L. Chapman, J. P. Burley, B. M. McQuillan, P. L. Thompson, and J. Hung. 2003. Apolipoprotein E gene polymorphisms are associated with carotid plaque formation but not with intima-media wall thickening: results from the Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Stroke. 34: 869-874.
59. Sass, C., F. Zannad, B. Herbeth, D. Salah, O. Chapet, G. Siest, and S. Visvikis. 1998. Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort. Atherosclerosis. 140: 89-95.
60. Hanon, O., X. Girerd, V. Luong, X. Jeunemaitre, S. Laurent, and M. E. Safar. 2000. Association between the apolipoprotein E polymorphism and arterial wall thickness in asymptomatic adults. J. Hypertens. 18: 431-436.
61. Horejsi, B., J. Spacil, R. Ceska, M. Vrablik, T. Haas, and A. Horinek. 2000. The independent correlation of the impact of lipoprotein(a) levels and apolipoprotein E polymorphism on carotid artery intima thickness. Int. Angiol. 19: 331-336.
62. Fernandez-Miranda, C., J. L. Aranda, M. A. Martin, J. Arenas, V. Nunez, and A. Gomez de la Camara. 2004. Apolipoprotein E polymorphism and carotid atherosclerosis in patients with coronary disease. Int. J. Cardiol. 94: 209-212.
63. Asakimori, Y., N. Yorioka, J. Tanaka, and N. Kohno. 2003. Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients. Am. J. Kidney Dis. 41: 822-832.
64. Volcik, K. A., R. A. Barkley, R. G. Hutchinson, T. H. Mosley, G. Heiss, A. R. Sharrett, C. M. Ballantyne, and E. Boerwinkle. 2006. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants. Am. J. Epidemiol. 164: 342-348.
65. Graner, M., J. Kahri, M. Varpula, R. M. Salonen, K. Nyyssonen, M. Jauhiainen, M. S. Nieminen, M. Syvanne, and M. R. Taskinen. 2007. Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease. Nutr. Metab. Cardiovasc. Dis. In press.
66. Eck, M. V., J. Oost, J. R. Goudriaan, M. Hoekstra, R. B. Hildebrand, I. S. Bos, K. W. van Dijk, and T. J. C. Van Berkel. 2005. Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. Atherosclerosis. 183: 230-237.
67. Hirschhorn, J. N., K. Lohmueller, E. Byrne, and K. Hirschhorn. 2002. A comprehensive review of genetic association studies. Genet. Med. 4: 45-61.
68. Ioannidis, J. P. A., E. E. Ntzani, T. A. Trikalinos, and D. G. Contopoulos-Ioannidis. 2001. Replication validity of genetic association studies. Nat. Genet. 29: 306-309.
69. Lohmueller, K. E., C. L. Pearce, M. Pike, E. S. Lander, and J. N. Hirschhorn. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet. 33: 177-182.
70. Herbert, A., N. P. Gerry, M. B. McQueen, I. M. Heid, A. Pfeufer, T. Illig, H. E. Wichmann, T. Meitinger, D. Hunter, F. B. Hu, et al. 2006. A common genetic variant is associated with adult and childhood obesity. Science. 312: 279-283.
71. Ioannidis, J. P. 2007. Non-replication and inconsistency in the genome-wide association setting. Hum. Hered. 64: 203-213.
72. Rosskopf, D., A. Bornhorst, C. Rimmbach, C. Schwahn, A. Kayser, A. Kruger, G. Tessmann, I. Geissler, H. K. Kroemer, and H. Volzke. 2007. Comment on "A common genetic variant is associated with adult and childhood obesity." Science. 315: 187d.
73. Dina, C., D. Meyre, C. Samson, J. Tichet, M. Marre, B. Jouret, M. A. Charles, B. Balkau, and P. Froguel. 2007. Comment on "A common genetic variant is associated with adult and childhood obesity." Science. 315: 187b.
74. Loos, R. J. F., I. Barroso, S. O'Rahilly, and N. J. Wareham. 2007. Comment on "A common genetic variant is associated with adult and childhood obesity." Science. 315: 187c.